Stem cell therapy: pieces of the puzzle
- PMID: 20119487
- PMCID: PMC2810366
- DOI: 10.1007/s12265-009-9148-z
Stem cell therapy: pieces of the puzzle
Abstract
Acute ischemic injury and chronic cardiomyopathies can cause irreversible loss of cardiac tissue leading to heart failure. Cellular therapy offers a new paradigm for treatment of heart disease. Stem cell therapies in animal models show that transplantation of various cell preparations improves ventricular function after injury. The first clinical trials in patients produced some encouraging results, despite limited evidence for the long-term survival of transplanted cells. Ongoing research at the bench and the bedside aims to compare sources of donor cells, test methods of cell delivery, improve myocardial homing, bolster cell survival, and promote cardiomyocyte differentiation. This article reviews progress toward these goals.
Similar articles
-
Cardiac regeneration therapy: connections to cardiac physiology.Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2169-80. doi: 10.1152/ajpheart.00768.2011. Epub 2011 Sep 30. Am J Physiol Heart Circ Physiol. 2011. PMID: 21963835 Review.
-
Myocardial cell sheet therapy and cardiac function.Am J Physiol Heart Circ Physiol. 2012 Nov 15;303(10):H1169-82. doi: 10.1152/ajpheart.00376.2012. Epub 2012 Sep 21. Am J Physiol Heart Circ Physiol. 2012. PMID: 23001836 Review.
-
Cardiac regeneration in 2017: Novel paradigms in the fight against heart failure.Nat Rev Cardiol. 2018 Jan 16;15(2):73-74. doi: 10.1038/nrcardio.2017.218. Nat Rev Cardiol. 2018. PMID: 29336435 Review. No abstract available.
-
Stem cell therapy for heart failure: Ensuring regenerative proficiency.Trends Cardiovasc Med. 2016 Jul;26(5):395-404. doi: 10.1016/j.tcm.2016.01.003. Epub 2016 Jan 28. Trends Cardiovasc Med. 2016. PMID: 27020904 Free PMC article. Review.
-
Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges.Circ J. 2012;76(6):1307-12. doi: 10.1253/circj.cj-11-1479. Epub 2012 May 19. Circ J. 2012. PMID: 22739079 Review.
Cited by
-
Time is like a clock in my heart: implications for stem cell delivery after myocardial infarction.Cardiology. 2010;117(2):158-60. doi: 10.1159/000321396. Epub 2010 Oct 30. Cardiology. 2010. PMID: 21042016 Free PMC article. No abstract available.
-
Standard operating procedures for maintaining cleanliness in a novel compact facility for breeding SPF mice.J Am Assoc Lab Anim Sci. 2013 Nov;52(6):717-24. J Am Assoc Lab Anim Sci. 2013. PMID: 24351759 Free PMC article.
-
Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model.Int J Nanomedicine. 2014;9:17-26. doi: 10.2147/IJN.S52005. Epub 2013 Dec 11. Int J Nanomedicine. 2014. PMID: 24376353 Free PMC article.
-
Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model.PLoS One. 2017 May 1;12(5):e0175807. doi: 10.1371/journal.pone.0175807. eCollection 2017. PLoS One. 2017. Retraction in: PLoS One. 2023 Nov 8;18(11):e0294365. doi: 10.1371/journal.pone.0294365. PMID: 28459804 Free PMC article. Retracted.
-
Pericardial application as a new route for implanting stem-cell cardiospheres to treat myocardial infarction.J Physiol. 2018 Jun;596(11):2037-2054. doi: 10.1113/JP275548. Epub 2018 May 7. J Physiol. 2018. PMID: 29736937 Free PMC article.
References
-
- Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–156. - PubMed
-
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MM, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147. - PubMed
-
- Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation Research. 2002;91:501–508. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases